Gene · 83990
Papers4,271
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,271
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline Pathogenic Variants in Patients With Pancreatic and Periampullary Cancers. | JCO Precis Oncol | 2024 | 38781545 | PubTator, text mining | PubMed |
| Prospective Study of Homologous Recombination Repair Gene Mutation Prevalence in Patients With Advanced Prostate Cancer From Latin America: Challenges and Future Approaches. | JCO Precis Oncol | 2024 | 38748947 | PubTator, text mining | PubMed |
| Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis. | Oncologist | 2024 | 38716772 | PubTator, text mining | PubMed |
| Spatial organization and functions of Chk1 activation by TopBP1 biomolecular condensates. | Cell Rep | 2024 | 38578830 | PubTator, text mining | PubMed |
| FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells. | Nat Commun | 2024 | 38521768 | PubTator, text mining | PubMed |
| Purification and biochemical characterization of the G4 resolvase and DNA helicase FANCJ. | Methods Enzymol | 2024 | 38521581 | PubTator, text mining | PubMed |
| Germline cancer susceptibility in individuals with melanoma. | J Am Acad Dermatol | 2024 | 38513832 | PubTator, text mining | PubMed |
| High Clinical Exome Sequencing Diagnostic Rates and Novel Phenotypic Expansions for Nonisolated Microphthalmia, Anophthalmia, and Coloboma. | Invest Ophthalmol Vis Sci | 2024 | 38502138 | PubTator, text mining | PubMed |
| Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer Centre. | Clin Genitourin Cancer | 2024 | 38461085 | PubTator, text mining | PubMed |
| A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR). | Oncologist | 2024 | 38452035 | PubTator, text mining | PubMed |
| Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes. | Ann Oncol | 2024 | 38417742 | PubTator, text mining | PubMed |
| Serous tubal intraepithelial carcinoma (STIC) outcomes in an average risk population. | Gynecol Oncol Rep | 2024 | 38370398 | PubTator, text mining | PubMed |
| Screening and prevention of ovarian cancer. | Med J Aust | 2024 | 38353066 | PubTator, text mining | PubMed |
| Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan. | J Biomed Sci | 2024 | 38350919 | PubTator, text mining | PubMed |
| Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer. | JAMA Netw Open | 2024 | 38334999 | PubTator, text mining | PubMed |
| MutSβ-MutLβ-FANCJ axis mediates the restart of DNA replication after fork stalling at cotranscriptional G4/R-loops. | Sci Adv | 2024 | 38324687 | PubTator, text mining | PubMed |
| Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast Cancer. | Cancer Res Commun | 2024 | 38315150 | PubTator, text mining | PubMed |
| Next Generation Sequencing Analysis of Fibrin-associated Large B-cell Lymphoma Reveals Pathogenic Single Nucleotide Variants. | Anticancer Res | 2024 | 38307569 | PubTator, text mining | PubMed |
| Next-generation sequencing-based analysis of homologous recombination repair gene variant in ovarian cancer. | Heliyon | 2024 | 38298632 | PubTator, text mining | PubMed |
| Splicing inhibition mediated by reduced splicing factors and helicases is associated with the cellular response of lung cancer cells to cisplatin. | Comput Struct Biotechnol J | 2024 | 38283853 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/83990/papers?page=12